Serotonin Receptor Agonists: all 773 studies that test it
Page 7 of 8. Open to participants first (148), then studies with results posted, then the rest; newest registration first within each.
- Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack StudyCompletedNCT01986088Phase 3
- Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute MigraineCompletedNCT01978496Phase 3
- Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot StudyStatus unknownNCT01962402Phase 4
- Pharmacokinetic Study of Belviq in Adult Korean VolunteersCompletedNCT01880502Phase 1
- Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled StudyCompletedNCT01878942Early Phase 1
- Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon CapsuleCompletedNCT01864915Phase 3
- Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose StudyCompletedNCT01859481Phase 3
- Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?TerminatedNCT01856127Phase 4
- Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic StrokeTerminatedNCT01833312Phase 3
- Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine TreatmentCompletedNCT01814189Phase 3
- Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory SystemsCompletedNCT01743235Phase 2
- Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.WithdrawnNCT01726920Phase 3
- Vilazodone for the Treatment of Posttraumatic Stress DisorderCompletedNCT01715519Phase 4
- Study of Vilazodone to Treat Social Anxiety DisorderStatus unknownNCT01712321Not applicable
- Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PETCompletedNCT01699828Phase 1/2
- Prucalopride Subjects With Renal ImpairmentCompletedNCT01674192Phase 1
- Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal RetentionCompletedNCT01674166Phase 1
- Prucalopride in Paediatric Subjects, With Functional Faecal RetentionCompletedNCT01670669Phase 1
- Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive CraniotomyCompletedNCT01632657Not applicable
- Safety and Efficacy of Vilazodone in Major Depressive DisorderCompletedNCT01573598Phase 4
- Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety DisorderWithdrawnNCT01546896Phase 4
- A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional ConstipationCompletedNCT01523184Phase 2
- Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy SubjectsCompletedNCT01507610Phase 1
- Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and ImitrexCompletedNCT01450995Phase 4
- Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum DisordersWithdrawnNCT01395953Phase 2
- Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy AdultsCompletedNCT01381796Phase 1
- Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional DyspepsiaCompletedNCT01355276Phase 3
- Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral OxygenationWithdrawnNCT01311414Not applicable
- Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military TroopsWithdrawnNCT01306266Not applicable
- Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET ImagingCompletedNCT01296802Not applicable
- An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes MellitusTerminatedNCT01286090Phase 4
- Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal GastrectomyCompletedNCT01284764Phase 3
- A Study of Cisapride in Premature Infants With Feeding ProblemsTerminatedNCT01281566Phase 4
- A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux DiseaseTerminatedNCT01281553Phase 4
- An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment OptionsTerminatedNCT01281540Phase 4
- Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of MigraineCompletedNCT01276977Not applicable
- Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed ConditionsCompletedNCT01269281Phase 1
- Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in AdultsCompletedNCT01266174Phase 2
- Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted ConditionsCompletedNCT01161667Not applicable
- Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed ConditionsCompletedNCT01161654Not applicable
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)CompletedNCT01161602Phase 2
- Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic ImpairmentCompletedNCT01134185Phase 1
- An Efficacy and Safety Study of Prucalopride in Participants With Chronic ConstipationCompletedNCT01116206Phase 3
- Effect of ATI-7505 on Gastrointestinal Transit in Healthy VolunteersCompletedNCT01094821Phase 1/2
- Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male VolunteersCompletedNCT01085123Phase 1
- Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic ConstipationCompletedNCT01070615Phase 3
- Rizatriptan 10 MG RPD in the Treatment of Acute MigraineCompletedNCT01057160Phase 4
- Frovatriptan as a Transitional Therapy in Medication Overuse HeadacheCompletedNCT01044251Phase 2
- M0001 Effects on Oral Contraceptive Plasma LevelsCompletedNCT01036893Phase 1
- Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) HeadachesCompletedNCT01035983Phase 3
- Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic ConstipationCompletedNCT00987844Phase 3
- Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV MelanomaWithdrawnNCT00979693Phase 2
- Comparative Formulation Study of VabicaserinCompletedNCT00928551Phase 1
- Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual MigraineCompletedNCT00904098Phase 4
- A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.TerminatedNCT00903838Phase 2
- Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG ParametersCompletedNCT00903747Phase 1
- Efficacy of Sumatriptan With Naprosyn in Migraine With AuraStatus unknownNCT00893594Not applicable
- An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)CompletedNCT00875784Phase 1
- Buspirone in the Treatment of 2-6 Year Old Children With Autistic DisorderCompletedNCT00873509Phase 2/3
- Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting ConditionsCompletedNCT00872924Not applicable
- Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed ConditionsCompletedNCT00872274Not applicable
- Buspirone Hydrochloride 30mg Tablets, FastingCompletedNCT00840606Phase 1
- Buspirone Hydrochloride 30mg Tablets, Non-FastingCompletedNCT00840398Phase 1
- Treximet in Acute Migraine Headache: Assessing Cognitive FunctionStatus unknownNCT00837044Not applicable
- To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food IntakeCompletedNCT00829140Phase 1
- Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic ImpairmentCompletedNCT00828932Phase 1
- Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted StateCompletedNCT00828724Phase 1
- Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly SubjectsCompletedNCT00828581Phase 1
- Pharmacokinetic Properties of Lorcaserin in Subjects With Renal ImpairmentCompletedNCT00828438Phase 1
- A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of MigraineCompletedNCT00821483Phase 3
- Psilocybin and Spiritual PracticeCompletedNCT00802282Phase 1
- Safety Study of Prucalopride in Healthy VolunteersCompletedNCT00793429Phase 1
- Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of SchizophreniaWithdrawnNCT00768612Phase 2
- Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine PeriodCompletedNCT00723983Phase 1
- Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy VolunteersCompletedNCT00720018Phase 1
- Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free IntervalsCompletedNCT00700128Not applicable
- Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting ConditionsCompletedNCT00653419Phase 1
- Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed ConditionsCompletedNCT00652730Phase 1
- Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mgCompletedNCT00650247Phase 1
- Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mgCompletedNCT00648466Phase 1
- A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual MigraineCompletedNCT00644033Phase 3
- ZAP, US. Zomig for Appropriate for Primary CareCompletedNCT00637286Phase 4
- Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory DrugsCompletedNCT00634985Phase 4
- Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan TherapyCompletedNCT00632385Phase 4
- Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00631813Phase 2
- A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress SyndromeTerminatedNCT00630370Phase 2
- Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing FacilityCompletedNCT00627692Phase 2
- Efficacy and Tolerability of Zolmitriptan Nasal SprayCompletedNCT00617747Phase 3
- Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in AdolescentsCompletedNCT00617695Phase 3
- Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00617513Phase 2
- Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic ConstipationCompletedNCT00598338Phase 3
- Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic ConstipationCompletedNCT00596596Phase 2
- Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic ConstipationCompletedNCT00577018Phase 3
- Effect of Prucalopride in Patients With Severe Chronic Idiopathic ConstipationCompletedNCT00576511Phase 2
- Prucalopride in Patients With Chronic Idiopathic ConstipationCompletedNCT00575614Phase 2
- A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic ConstipationTerminatedNCT00563758Not applicable
- Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic MethodStatus unknownNCT00563615Not applicable
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in FemalesStatus unknownNCT00547469Phase 2/3
- Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®CompletedNCT00546650Phase 1
- Study Comparing Bioavailability of Oral Formulations of VabicaserinCompletedNCT00541996Phase 1